Clinical Trial

A Study to Evaluate Mosunetuzumab in Participants With Systemic Lupus Erythematosus With or Without Active Lupus Nephritis

Study acronym: SOLUNA
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This study will assess how mosunetuzumab works in people who have systemic lupus erythematosus (SLE) who may or may not also have active lupus nephritis (LN).
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2026-05-14; most recent amendment 2026-07-24.
Trial Details
NCT Number NCT07598396
Lead Sponsor Hoffmann-La Roche
Conditions Lupus, Systemic Lupus Erythematosus, Lupus Nephritis
Enrollment 30 participants
Start Date 2026-05-25
Primary Completion 2028-02-28 (estimated)
Study Completion 2028-08-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-27